Search

Your search keyword '"Li, Bob"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Li, Bob" Remove constraint Author: "Li, Bob" Publisher elsevier bv Remove constraint Publisher: elsevier bv
40 results on '"Li, Bob"'

Search Results

1. Optimal Systemic Treatment and Real-World Clinical Application of Ctdna in Patients with Metastatic Her2-Mutant Lung Cancer

2. Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC

3. A tailored approach to horizon scanning for cancer medicines

4. A tailored approach to horizon scanning for cancer medicines

5. Genomic mapping of metastatic organotropism in lung adenocarcinoma

6. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

7. Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

8. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

9. Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib

11. Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies

12. Characterization of Central Nervous System Clinico-Genomic Outcomes In  ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

13. Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

15. Corrigendum to “Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions” [Lung Cancer 159 (2021) 66–73]

16. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

17. Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion

19. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

21. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

22. Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers

23. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

29. The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials

31. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement

32. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration

Catalog

Books, media, physical & digital resources